Studies of early-onset forms of familial AD, Down syndrome, and transgenic rodent models that overexpress normal or mutated forms of the amyloid precursor protein (APP) suggest formation of amyloid plaques may play a key role in the disease [1, 2]. This evidence concerns the gene APP and Down syndrome.